SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-006768
Filing Date
2020-01-14
Accepted
2020-01-14 08:01:13
Documents
36
Period of Report
2020-01-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d866623d8k.htm 8-K 20292
2 EX-99.1 d866623dex991.htm EX-99.1 61483
3 GRAPHIC g866623ex99_1p10g1.jpg GRAPHIC 213901
4 GRAPHIC g866623ex99_1p11g1.jpg GRAPHIC 150486
5 GRAPHIC g866623ex99_1p12g1.jpg GRAPHIC 275451
6 GRAPHIC g866623ex99_1p13g1.jpg GRAPHIC 238482
7 GRAPHIC g866623ex99_1p14g1.jpg GRAPHIC 186406
8 GRAPHIC g866623ex99_1p15g1.jpg GRAPHIC 195049
9 GRAPHIC g866623ex99_1p16g1.jpg GRAPHIC 220458
10 GRAPHIC g866623ex99_1p17g1.jpg GRAPHIC 184204
11 GRAPHIC g866623ex99_1p18g1.jpg GRAPHIC 212710
12 GRAPHIC g866623ex99_1p19g1.jpg GRAPHIC 218316
13 GRAPHIC g866623ex99_1p1g1.jpg GRAPHIC 217453
14 GRAPHIC g866623ex99_1p20g1.jpg GRAPHIC 280882
15 GRAPHIC g866623ex99_1p21g1.jpg GRAPHIC 266629
16 GRAPHIC g866623ex99_1p22g1.jpg GRAPHIC 207383
17 GRAPHIC g866623ex99_1p23g1.jpg GRAPHIC 198519
18 GRAPHIC g866623ex99_1p24g1.jpg GRAPHIC 190670
19 GRAPHIC g866623ex99_1p25g1.jpg GRAPHIC 219077
20 GRAPHIC g866623ex99_1p26g1.jpg GRAPHIC 149934
21 GRAPHIC g866623ex99_1p27g1.jpg GRAPHIC 239182
22 GRAPHIC g866623ex99_1p28g1.jpg GRAPHIC 276267
23 GRAPHIC g866623ex99_1p29g1.jpg GRAPHIC 227077
24 GRAPHIC g866623ex99_1p2g1.jpg GRAPHIC 543236
25 GRAPHIC g866623ex99_1p30g1.jpg GRAPHIC 252782
26 GRAPHIC g866623ex99_1p31g1.jpg GRAPHIC 301119
27 GRAPHIC g866623ex99_1p32g1.jpg GRAPHIC 227407
28 GRAPHIC g866623ex99_1p33g1.jpg GRAPHIC 230244
29 GRAPHIC g866623ex99_1p34g1.jpg GRAPHIC 202255
30 GRAPHIC g866623ex99_1p3g1.jpg GRAPHIC 143129
31 GRAPHIC g866623ex99_1p4g1.jpg GRAPHIC 283765
32 GRAPHIC g866623ex99_1p5g1.jpg GRAPHIC 321009
33 GRAPHIC g866623ex99_1p6g1.jpg GRAPHIC 314059
34 GRAPHIC g866623ex99_1p7g1.jpg GRAPHIC 327089
35 GRAPHIC g866623ex99_1p8g1.jpg GRAPHIC 349906
36 GRAPHIC g866623ex99_1p9g1.jpg GRAPHIC 248396
  Complete submission text file 0001193125-20-006768.txt   11537267
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39112 | Film No.: 20524985
SIC: 2836 Biological Products, (No Diagnostic Substances)